GLP-1-RA: Pfizer to continue danuglipron but discontinue lotiglipron
Pfizer will continue to progress its first full agonist oral glucagon-like peptide-1 receptor agonist (GLP-1-RA) candidate - danuglipron...
top of page
Browse by category
Search
Browse by tag
bottom of page